Clinical trials represent the crucial interface between innovative cancer research and successful therapy. They give patients direct access to the latest therapeutic developments and provide the possibility of promptly benefiting from current research findings. The program "Entwicklung klinischer Studien" (Development of Clinical Trials) accelerates the transfer of research findings into clinical practice through professional support of investigator-initiated trials (IITs).
In the preclinical phase, these are supported by strategic advice. The program also provides assistance in the financing and contractual phases; with coordination of regulatory requirements, documentation, data management and statistical analysis; as well as with services such as registration and medical advice.
Please understand that some clinical trials are not listed for reasons of confidentiality. An assessment as to the suitability of a patient for inclusion in a clinical trial is made by the tumor board. The NCT trial center provides appropriate information in cooperation with the individuals and institutions conducting the clinical trial.